Taçyıldız, Nurdan, et al. “A Targeted Salvage Therapy With Brentuximab Vedotin in Heavily Treated Refractory or Relapsed Pediatric Hodgkin Lymphoma Patients before and After Stem Cell Transplantation”. The Turkish Journal of Pediatrics, vol. 61, no. 5, Oct. 2019, pp. 671-6, https://doi.org/10.24953/turkjped.2019.05.005.